Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neuroectodermal Tumors, Primitive × Eflornithine × 30 days × Clear all

Status

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Conditions

Neuroblastoma 3 Medulloblastoma 2 Typical Teratoid Rhabdoid Tumor 1 Neuroectodermal Tumors, Primitive 1 Melanoma 1 Lung Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 Breast Neoplasms 1

Interventions

gallium Ga 68 dotatate 1 Eflornithine 1 CLR1404 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03581240 2026-02-20

An Intermediate Expanded Use Trial of DFMO

Milton S. Hershey Medical Center

Typical Teratoid Rhabdoid Tumor, Medulloblastoma, Neuroblastoma, Neuroectodermal Tumors, Primitive

Data powered by HemOnc (CC BY 4.0) Colophon ⚡